Patents by Inventor Katherine Lovejoy

Katherine Lovejoy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240156964
    Abstract: The compositions and methods described herein are topically applied to the skin with negligible or no skin irritation and can direct or prevent transport through the skin. The compositions contain neat ionic liquids, optionally in combination with a drug to be delivered. In a preferred embodiment, the compositions increase transdermal transport of the drug to be delivered. In some embodiments, the compositions disrupt bacterial biofilms. This is particularly beneficial in the treatment of antibiotic resistant skin infections. In other embodiments, the compositions direct delivery within the skin. In still other embodiments, the compositions prevent transfer of substances through the stratum corneum. The disclosed compositions and methods can be tuned and modified such that they can be used to treat or prevent a variety of different diseases and disorders.
    Type: Application
    Filed: September 22, 2023
    Publication date: May 16, 2024
    Inventors: Michael Zakrewsky, Samir Mitragotri, David T. Fox, Andrew Koppisch, Rico Del Sesto, Katherine Lovejoy
  • Patent number: 11786597
    Abstract: The compositions and methods described herein are topically applied to the skin with negligible or no skin irritation and can direct or prevent transport through the skin. The compositions contain neat ionic liquids, optionally in combination with a drug to be delivered. In a preferred embodiment, the compositions increase transdermal transport of the drug to be delivered. In some embodiments, the compositions disrupt bacterial biofilms. This is particularly beneficial in the treatment of antibiotic resistant skin infections. In other embodiments, the compositions direct delivery within the skin. In still other embodiments, the compositions prevent transfer of substances through the stratum corneum. The disclosed compositions and methods can be tuned and modified such that they can be used to treat or prevent a variety of different diseases and disorders.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: October 17, 2023
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, TRIAD NATIONAL SECURITY, LLC, THE ARIZONA BOARD OF REGENTS
    Inventors: Michael Zakrewsky, Samir Mitragotri, David T. Fox, Andrew Koppisch, Rico Del Sesto, Katherine Lovejoy
  • Publication number: 20190388545
    Abstract: The compositions and methods described herein are topically applied to the skin with negligible or no skin irritation and can direct or prevent transport through the skin. The compositions contain neat ionic liquids, optionally in combination with a drug to be delivered. In a preferred embodiment, the compositions increase transdermal transport of the drug to be delivered. In some embodiments, the compositions disrupt bacterial biofilms. This is particularly beneficial in the treatment of antibiotic resistant skin infections. In other embodiments, the compositions direct delivery within the skin. In still other embodiments, the compositions prevent transfer of substances through the stratum corneum. The disclosed compositions and methods can be tuned and modified such that they can be used to treat or prevent a variety of different diseases and disorders.
    Type: Application
    Filed: June 21, 2019
    Publication date: December 26, 2019
    Inventors: Michael Zakrewsky, Samir Mitragotri, David T. Fox, Andrew Koppisch, Rico Del Sesto, Katherine Lovejoy
  • Patent number: 10449254
    Abstract: The compositions and methods described herein are topically applied to the skin with negligible or no skin irritation and can direct or prevent transport through the skin. The compositions contain neat ionic liquids, optionally in combination with a drug to be delivered. In a preferred embodiment, the compositions increase transdermal transport of the drug to be delivered. In some embodiments, the compositions disrupt bacterial biofilms. This is particularly beneficial in the treatment of antibiotic resistant skin infections. In other embodiments, the compositions direct delivery within the skin. In still other embodiments, the compositions prevent transfer of substances through the stratum corneum. The disclosed compositions and methods can be tuned and modified such that they can be used to treat or prevent a variety of different diseases and disorders.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: October 22, 2019
    Assignees: The Regents of the University of California, Triad National Security, LLC, Arizona Board of Regents c/o Northern Arizona University
    Inventors: Michael Zakrewsky, Samir Mitragotri, David T. Fox, Andrew Koppisch, Rico Del Sesto, Katherine Lovejoy
  • Publication number: 20160263225
    Abstract: The compositions and methods described herein are topically applied to the skin with negligible or no skin irritation and can direct or prevent transport through the skin. The compositions contain neat ionic liquids, optionally in combination with a drug to be delivered. In a preferred embodiment, the compositions increase transdermal transport of the drug to be delivered. In some embodiments, the compositions disrupt bacterial biofilms. This is particularly beneficial in the treatment of antibiotic resistant skin infections. In other embodiments, the compositions direct delivery within the skin. In still other embodiments, the compositions prevent transfer of substances through the stratum corneum. The disclosed compositions and methods can be tuned and modified such that they can be used to treat or prevent a variety of different diseases and disorders.
    Type: Application
    Filed: November 3, 2014
    Publication date: September 15, 2016
    Inventors: Michael Zakrewsky, Samir Mitragotri, David T. Fox, Andrew Koppisch, Rico Del Sesto, Katherine Lovejoy
  • Publication number: 20130252818
    Abstract: An amorphous formulation of a herbicidal or pesticidal substance includes a composition of the formula [A]x[MpClq]y, the composition being an ionic liquid with a melting temperature below 150° C., wherein [MpClq] is a metal chloride, x is 1, 2, 3, or 4, p is 1, 2, 3, or 4, q is 1, 2, 3, 4, 5, 6, 7, 8, or 9, and y is 1 or 2, wherein each A is a cation that is a herbicidal or pesticidal substance or a cation precursor that is a herbicidal or pesticidal substance.
    Type: Application
    Filed: March 25, 2013
    Publication date: September 26, 2013
    Inventors: Katherine Lovejoy, Rico Del Sesto, Andrew Koppisch
  • Publication number: 20130252945
    Abstract: An amorphous formulations of a pharmaceutical includes a composition of the formula [A]x[MpClq]y, the composition being an ionic liquid with a melting temperature below 150° C., wherein [MpClq] is a metal chloride, x is 1, 2, 3, or 4, p is 1, 2, 3, or 4, q is 1, 2, 3, 4, 5, 6, 7, 8, or 9, and y is 1 or 2, wherein each A is a cation that is a pharmaceutical or a cation precursor that is a pharmaceutical.
    Type: Application
    Filed: March 25, 2013
    Publication date: September 26, 2013
    Inventors: Katherine Lovejoy, Rico Del Sesto, Andrew Koppisch